Project Brief

A South Korea-based medical-device company is evaluating the Singapore market for its digital injection technologies.

Its current product, i-JECT B, is a cordless, handheld automatic injector developed for professional aesthetic procedures, including botulinum toxin and other compatible low-volume injections. The device is designed to support controlled injection speed and pressure, precise dose delivery, auto-aspiration and improved clinician ergonomics.

The company is also developing a future self-injection platform intended to improve injection control, dose confirmation, adherence monitoring and treatment records for patients using repeated injectable therapies.

Project Overview

1. i-JECT B Commercial Opportunity

• Clinical value compared with manual syringes

• Priority aesthetic applications and customer segments

• Product differentiation and adoption barriers

• Pricing and suitable commercial models

• Distribution channels and after-sales requirements

• Regulatory requirements and market-entry considerations

• Near-term sales and market potential

2. Future Self-Injection Platform

• Therapy areas with unmet self-injection needs

• Required product capabilities and usability considerations

• Potential clinical pilots and validation studies

• Joint R&D and co-development opportunities

• Potential collaboration with Singapore healthcare institutions and industry partners

Advisors Needed

Industry Expert Specialties:

• Sales, marketing, business-development or distribution professionals in medical aesthetics

• Experience with aesthetic devices, injectable products, dermatology or plastic-surgery portfolios

• Minimum five years of relevant industry experience

Medical Expert Specialties:

• Aesthetic physicians, dermatologists or plastic surgeons

• Minimum five years of relevant clinical experience in Singapore

• Regularly perform or supervise botulinum toxin, skin-booster, PDRN/polynucleotide or other injectable aesthetic procedures

Geographical Focus Key Regions: Singapore

Work Required: Advisors will be provided with a detailed background document on the company and its flagship product, including its features, benefits, and the company’s vision for a new orthodontic treatment journey.

Survey Completion: Experts will provide detailed feedback through a survey consisting of approximately 25-30 multiple-choice and open-ended questions focused on market potential, usability, and clinical impact.

Estimated Time Commitment: ~1 hour